This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on ISI (1)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Gastrointestinal Diseases  • Malabsorption Syndromes  • Alert me on articles by topic

Bridget M. Kuehn

JAMA. 2006;296:382.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Patients with celiac disease may one day have a treatment that will help them digest hidden gluten in foods or allow them to enjoy a somewhat less restrictive diet.

Between 0.5% and 1% of individuals in the United States and Europe are believed to have celiac disease, and their inability to digest gluten protein in wheat and other grains may lead to serious gastrointestinal tract complications (van Heel DA and West J. Gut. 2006;55:1037-1046). Complications of celiac disease may include malnutrition, anemia, cancer, osteoporosis, and poor pregnancy outcomes.

Currently, the only treatment for patients with celiac disease is complete exclusion of foods such as breads, pastas, and many processed foods that contain gluten. Doing so is difficult, however, because gluten is ubiquitous and may not be listed as an ingredient in many food products. But recent research suggests that oral formulations of enzymes that are able . . . [Full Text of this Article]

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

CLINICAL ENZYMOLOGY: Enzymes As Medicine
Scheindlin
Mol. Interv. 2007;7:4-8.
FULL TEXT